Mirae Asset Global Etfs Holdings Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,858 shares of MDGL stock, worth $3.78 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,858
Previous 14,162
2.15%
Holding current value
$3.78 Million
Previous $4.37 Million
5.06%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MDGL
# of Institutions
366Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$601 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$572 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$551 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$544 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$538 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.66B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...